Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 43, 2014 - Issue 4
172
Views
6
CrossRef citations to date
0
Altmetric
Research Article

A high frequency of peripheral blood NKG2D+NK and NKT cells in euthyroid patients with new onset hashimoto’s thyroiditis—a pilot study

, , , , , & show all

References

  • Amino N, Mori H, Iwatani Y, et al. (1982). Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves’ disease and increase in Hashimoto’s disease. J Clin Endocrinol Metab, 54, 587–91
  • Bahram S, Inoko H, Shiina T, Radosavljevic M. (2005). MIC and other NKG2D ligands: from none to too many. Curr Opin Immunol, 17, 505–9
  • Balashov KE, Khoury SJ, Hafler DA, Weiner HL. (1995). Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. J Clin Invest, 95, 2711–9
  • Baxter AG, Smyth MJ. (2002). The role of NK cells in autoimmune disease. Autoimmunity, 35, 1–14
  • Calder EA, Irvine WJ, Davidson NM, Wu FT. (1976). B and K cells in autoimmune thyroid disease. Clin Exp Immunol, 25, 17–23
  • Carbone E, Neri P, Mesuraca M, et al. (2005). HLA class I, NKG2D and natu -ral cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood, 105, 251–8
  • Coudert JD, Held W. (2006). The role of the NKG2D receptor for tumor immunity. Semin Cancer Biol, 16, 333–43
  • del Prete GF, Maggi E, Mariotti S, et al. (1986). Cytolytic T lymphocytes with natural killer activity in thyroid infiltrate of patients with Hashimoto's thyroiditis: analysis at clonal level. J Clin Endocrinol Metab, 62, 52–7
  • Doniach D. (1975). Humoral and genetic aspects of thyroid auto-immunity. J Clin Endocrinol Metab, 4, 267–85
  • Fuertes MB, Girart MV, Molinero LL, et al. (2008). Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. J Immunol, 180, 4606–14
  • Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. (2011). Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res, 31, 721–31
  • Goto M, Tanimoto K, Chihara T, Horiuchi Y. (1981). Natural cell-mediated cytotoxicity in Sjogren’s syndrome and rheumatoid arthritis. Arthritis Rheum, 24, 1377–82
  • Hervier B, Beziat V, Haroche J, et al. (2011). Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease. Arthritis Rheum, 63, 1698-706
  • Hollowell JG, Staehling NW, Flanders WD, et al. (2002). Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab, 87, 489–99
  • Lanier LL, Le AM, Civin CI, et al. (1986). The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol, 136, 4480–6
  • Mariotti S, Caturegli P, Piccolo P, et al. (1990). Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab, 71, 661–9
  • Martínez-Rodríguez JE, López-Botet M, Munteis E, et al. (2011). Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis. Clin Immunol, 141, 348–56
  • Miyake S, Yamamura T. (2007). NKT cells and autoimmune diseases: unraveling the complexity. Curr Top Microbiol Immunol, 314, 251–67
  • Papic M, Stein-Streilein J, Zakarija M, et al. (1987). Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J Clin Invest, 79, 404–8
  • Park MJ, Bae JH, Chung JS, et al. (2011). Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy. Immunol Investig, 40, 367–82
  • Pedersen BK, Feldt-Rasmussen U, Bech K, et al. (1989). Characterization of the natural killer activity in Hashimoto’s and Graves’ diseases. Allergy, 44, 477–81
  • Pende D, Cantoni C, Rivera P, et al. (2001). Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recog -nizing tumors of nonepithelial origin. Eur J Immunol, 31, 1076–86
  • Rodacki M, Svoren B, Butty V, et al. (2007). Altered natural killer cells in type 1 diabetic patients. Diabetes, 56, 177–85
  • Roman-Gonzalez A, Moreno ME, Alfaro JM, et al. (2009). Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients. Hum Immunol, 70, 262–8
  • Schade RO, Owen SG, Smart GA, Hall R. (1960). The relation of thyroid auto-immunity to round-celled infiltration of the thyroid gland. J Clin Pathol, 13, 499–501
  • Schmidt RE, Murray C, Daley JF, et al. (1986). A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med, 164, 351–6
  • Schroder K, Hertzog PJ, Ravasi T, Hume DA. (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol, 75, 163–89
  • Sivori S, Parolini S, Marcenaro E, et al. (2000). Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J Neuroimmunol, 107, 220–5
  • Solerte SB, Precerutti S, Gazzaruso C, et al. (2005). Defect of a subpopulation of natural killer immune cells in Graves’ disease and Hashimoto’s thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Eur J Endocrinol, 152, 703–12
  • Stassi G, De Maria R. (2002). Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol, 2, 195–204
  • Strehl B, Seifert U, Krüger E, et al. (2005). Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol Rev, 207, 19–30
  • Verneris MR, Karami M, Baker J, et al. (2004). Role of NKG2D signaling in the cytotoxic -ity of activated and expanded CD8+T cells. Blood, 103, 3065–72
  • Vitti P, Rago T. (2003). Thyroid ultrasound as a predicator of thyroid disease. J Endocrinol Invest, 26, 686–9
  • Wagtmann N, Rajagopalan S, Winter CC, et al. (1995). Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity, 3, 801–9
  • Wakil AE, Wang ZE, Ryan JC, et al. (1998). Interferon gamma derived from CD4(+) T cells is sufficient to mediate T helper cell type 1 development. J Exp Med, 188, 1651–6
  • Wenzel B, Chow A, Schleusener H, Wall JR. (1981). NK cell activity in autoimmune thyroid disorders. Proceedings of the 57th Annual Meeting of the American Thyroid Association. Minneapolis Abstract T26. Minneapolis, September 1981
  • Yabuhara A, Yang FC, Nakazawa T, et al. (1996). A killing defect of natural killer cells as an underlying immunological abnormality in childhood systemic lupus erythematosus. J Rheumatol, 23, 171–7
  • Yoshida H, Amino N, Yagawa K, et al. (1978). Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab, 46, 859–62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.